Kinetic compartment modeling of [11C]-5-hydroxy-L-tryptophan for positron emission tomography assessment of serotonin synthesis in human brain. 2002

Gisela E Hagberg, and Richard Torstenson, and Ina Marteinsdottir, and Mats Fredrikson, and Bengt Långström, and Gunnar Blomqvist
Uppsala University PET center, Institute of Psychiatry, Sweden. g.hagberg@hsantalucia.it

The substrate for the second enzymatic step in serotonin synthesis, 5-hydroxy-L-tryptophan, labeled in the beta-position ([11C]-HTP), was used for positron emission tomography (PET) measurements in six healthy human participants, examined on two occasions. One- and two-tissue kinetic compartment modeling of time-radioactivity curves was performed, using arterial, metabolite-corrected [11C]-HTP values as input function. The availability of unchanged tracer in arterial blood plasma was > or = 80% up to 60 minutes after injection, while [11C]-hydroxyindole acetic acid and [11C]-serotonin accounted for the remaining radioactivity, amounting to < or = 16% and < or = 4%, respectively. Compartment modeling was performed for brain stem, putamen, caudate nucleus, anterior cingulate, white matter, and superior occipital, occipitotemporal, and temporal cortices. The average biologic half-life for plasma-to-tissue equilibrium was 7 to 12 minutes, and the volume of distribution was 0.2 to 0.5 microL.mL(-1). In all regions except white matter, the kinetic compartment model that included irreversible [11C]-HTP trapping showed significantly improved model fits with respect to a one-tissue compartment model. The [11C]-HTP trapping rate constant depended on the estimated tissue availability of the serotonin precursor tryptophan, known to reflect serotonin synthesis in healthy individuals, and correlated with serotonin tissue concentration and synthesis rates reported previously in literature. These findings suggest the use of [11C]-HTP PET measurements to investigate serotonin synthesis.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006916 5-Hydroxytryptophan The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant. 5-HTP,Hydroxytryptophan,Oxitriptan,Oxytryptophan,Tryptophan, 5-Hydroxy-,5 Hydroxytryptophan,5-Hydroxy- Tryptophan,Tryptophan, 5 Hydroxy

Related Publications

Gisela E Hagberg, and Richard Torstenson, and Ina Marteinsdottir, and Mats Fredrikson, and Bengt Långström, and Gunnar Blomqvist
April 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
Gisela E Hagberg, and Richard Torstenson, and Ina Marteinsdottir, and Mats Fredrikson, and Bengt Långström, and Gunnar Blomqvist
January 2000, Nuclear medicine and biology,
Gisela E Hagberg, and Richard Torstenson, and Ina Marteinsdottir, and Mats Fredrikson, and Bengt Långström, and Gunnar Blomqvist
October 2014, Diabetes,
Gisela E Hagberg, and Richard Torstenson, and Ina Marteinsdottir, and Mats Fredrikson, and Bengt Långström, and Gunnar Blomqvist
November 1998, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Gisela E Hagberg, and Richard Torstenson, and Ina Marteinsdottir, and Mats Fredrikson, and Bengt Långström, and Gunnar Blomqvist
May 1995, Synapse (New York, N.Y.),
Gisela E Hagberg, and Richard Torstenson, and Ina Marteinsdottir, and Mats Fredrikson, and Bengt Långström, and Gunnar Blomqvist
September 2000, Journal of psychiatry & neuroscience : JPN,
Gisela E Hagberg, and Richard Torstenson, and Ina Marteinsdottir, and Mats Fredrikson, and Bengt Långström, and Gunnar Blomqvist
January 1992, Journal of neural transmission. General section,
Gisela E Hagberg, and Richard Torstenson, and Ina Marteinsdottir, and Mats Fredrikson, and Bengt Långström, and Gunnar Blomqvist
January 2014, Molecular imaging,
Gisela E Hagberg, and Richard Torstenson, and Ina Marteinsdottir, and Mats Fredrikson, and Bengt Långström, and Gunnar Blomqvist
March 2003, Canadian journal of gastroenterology = Journal canadien de gastroenterologie,
Gisela E Hagberg, and Richard Torstenson, and Ina Marteinsdottir, and Mats Fredrikson, and Bengt Långström, and Gunnar Blomqvist
March 2002, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR),
Copied contents to your clipboard!